WIM
DNA icon

Westside Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Westside Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35
Closed -$2.53K – 873
2023
Q3 		$2.53K Hold
35
– – ﹤0.01% 760
2023
Q2 		$2.6K Hold
35
– – ﹤0.01% 755
2023
Q1 		$1.86K Hold
35
– – ﹤0.01% 769
2022
Q4 		$2 Hold
35
– – ﹤0.01% 757
2022
Q3 		$4 Hold
35
– – ﹤0.01% 700
2022
Q2 		$3 Buy
+35
New +$4.27K ﹤0.01% 728
2022
Q1 		– Sell
-18
Closed -$5 – 781
2021
Q4 		$5 Buy
+18
New +$8.55K ﹤0.01% 664

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westside Investment Management's DNA Position: Q4 2023 in Review

Westside Investment Management sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 35 shares — an estimated $2.53K sold.

Westside Investment Management first reported a position in DNA in Q4 2021 and held it in 7 quarters. The position peaked at $2.6K in Q2 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Westside Investment Management reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Westside Investment Management sold 35 Ginkgo Bioworks shares in Q4 2023, an estimated $2.53K.
  • Westside Investment Management first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 7 quarters.
  • Westside Investment Management's Ginkgo Bioworks position peaked at $2.6K in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Westside Investment Management's 13F filing for Q4 2023, filed 12 Jan 2024.